COMMUNIQUÉS West-GlobeNewswire

Extendicare Announces Appointment of Al Mawani to Board of Directors
01/12/2017
MARKHAM, Ontario, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) today announced the appointment of Al Mawani to its Board of Directors, effective immediately, for a term [...]
Athenex Announces Planned Retirement of Chief Financial Officer Nick Riehle
01/12/2017
BUFFALO, N.Y., Dec. 01, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
California Medical Groups Honored for High-Quality Care of Medicare Advantage Patients
01/12/2017
OAKLAND, Calif., Dec. 01, 2017 (GLOBE NEWSWIRE) -- Almost a third of medical groups statewide achieved top honors for providing high-quality care to Medicare Advantage patients, according to the Integrated Healthcare [...]
AzurRx BioPharma to Present at the 2017 LD Micro 10th Annual Main Event Conference (December 5th)
01/12/2017
BROOKLYN, N.Y., Dec. 01, 2017 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc.(NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]
Faron Pharmaceuticals Oy: Appointment of Chief Commercial Officer
01/12/2017
Faron Pharmaceuticals Oy ("Faron" or the "Company") Appointment of Chief Commercial Officer Dr. Juhana Heinonen, previously AstraZeneca's Global Marketing Director, to steer commercialisation strategy for Faron's lead [...]
Curis Announces Upcoming Presentation at the American Society of Hematology 59th Annual Meeting & Exposition
01/12/2017
LEXINGTON, Mass., Dec. 01, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ: CRIS ), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for the treatment of [...]
Arog Pharmaceuticals Receives FDA Fast Track Designation for Crenolanib in Relapsed or Refractory FLT3-Positive AML
01/12/2017
DALLAS, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Arog Pharmaceuticals, Inc., a privately held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs to treat unmet [...]
Axsome Therapeutics Announces $9.5 Million Registered Direct Offering Priced At-the-Market
01/12/2017
NEW YORK, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM ), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]
Notice Received Under Section 249D of the Corporations Act
01/12/2017
MELBOURNE, Australia, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ: GENE ) (“Company”), advises that on 29 November it received a notice under Section 249D of the Corporations Act [...]
Employee elected board member change in Zealand Pharma
01/12/2017
Company announcement - No. 54/2017 Employee elected board member change in Zealand Pharma Copenhagen, December 1, 2017 - Zealand Pharma A/S ("ZEAL") announces that Rasmus Just, Director of Business Development and [...]
Photocure ASA: Blue Light Flexible Cystoscopy with Cysview® Phase 3 study: New data presented at Society of Urological Oncology
01/12/2017
Oslo, Norway, December 1, 2017 Photocure ASA (OSE: PHO) announced today that more detailed data from the Phase 3 study data was presented at the prestigious Society of Urologic Oncology, Annual Meeting November 29 - [...]
Nexstim Plc Appoints Steve Beller as Vice President and General Manager, North America
01/12/2017
Company announcement, Helsinki, 1 December 2017 at 9 am Nexstim Plc Appoints Steve Beller as Vice President and General Manager, North America Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or " Company "), a medical [...]
Basilea extends existing license agreement with Pfizer for antifungal Cresemba® (isavuconazole) to China and Asia Pacific
01/12/2017
Basilea eligible to receive additional upfront and milestone payments of up to USD 226 million and mid-teen royalties on sales Basilea updates its financial guidance for 2017 - improved result expected Basel, [...]
Cannabis Wheaton Income Corp. Announces Option Grant
01/12/2017
VANCOUVER, British Columbia, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V:CBW) (" Wheaton Income " or the " Company ") announces that it has granted 6,045,000 options to [...]
Veloxis Increases Share Capital in Connection with Exercise of Warrants
01/12/2017
Company Release no. 24/2017 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 01 December 2017 Veloxis Increases Share Capital in Connection with Exercise of Warrants Veloxis Pharmaceuticals A/S announces that the Company' [...]
CORRECTION -- Skyline Medical Inc. Announces the Completion of Private Placement for Gross Proceeds of $1,300,000
01/12/2017
BOCA RATON, Fla., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Please note that this is a headline correction for a release published earlier today for Skyline Medical Inc. The original release follows. Dawson James Securities, [...]
Globus Medical Announces Clinical Results Showing Superiority of its SECURE-C® to ACDF at Seven Years
01/12/2017
AUDUBON, Pa., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED ), a leading musculoskeletal solutions company, today announced the results of its seven-year clinical trial follow-up that demonstrate [...]
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/12/2017
CAMBRIDGE, Mass., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to [...]
Bellerophon Appoints Ted Wang, Ph.D., of Puissance Capital Management, to its Board of Directors
30/11/2017
WARREN, N.J., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH ), a clinical-stage biotherapeutics company, today announced the appointment of Ted Wang, Ph.D., Chief Investment Officer of [...]

Pages